Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
14,866
datasets available to search
ShareScore release 0.9.0
Dataset results
14,866 results for “cancer cell”
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT07111520. IPD Sharing: NO. Countries: 2. Publications: 0.
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
ClinicalTrials.gov study NCT06698042. IPD Sharing: YES. Countries: 12. Publications: 0.
Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib
ClinicalTrials.gov study NCT00473486. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT02448251. IPD Sharing: NO. Countries: 3. Publications: 0.
Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)
ClinicalTrials.gov study NCT04928222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation
ClinicalTrials.gov study NCT03693339. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06055465. IPD Sharing: NO. Countries: 1. Publications: 0.
Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
ClinicalTrials.gov study NCT00060307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
ClinicalTrials.gov study NCT07288034. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05513664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
ClinicalTrials.gov study NCT00602433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03451526. IPD Sharing: NO. Countries: 1. Publications: 0.
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00283478. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT01194050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer
ClinicalTrials.gov study NCT04192682. IPD Sharing: NO. Countries: 1. Publications: 0.
Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT07323641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers
ClinicalTrials.gov study NCT01871454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07355205. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT03941457. IPD Sharing: NO. Countries: 1. Publications: 0.
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
ClinicalTrials.gov study NCT02940977. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.